| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.66▼ | 5.65▲ | 5.67▼ | 5.71▼ | 5.73▼ |
| MA10 | 5.65▲ | 5.68▼ | 5.66▲ | 5.65▲ | 5.93▼ |
| MA20 | 5.65▲ | 5.64▲ | 5.68▼ | 5.69▼ | 7.12▼ |
| MA50 | 5.66▼ | 5.73▼ | 5.67▼ | 5.98▼ | 10.44▼ |
| MA100 | 5.64▲ | 5.66▼ | 5.60▲ | 7.27▼ | 14.04▼ |
| MA200 | 5.74▼ | 5.63▲ | 5.87▼ | 9.72▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.003▲ | -0.002▼ | 0.043▲ | 0.091▲ |
| RSI | 51.273▲ | 48.711▼ | 48.530▼ | 45.476▼ | 32.793▼ |
| STOCH | 70.000 | 29.539 | 54.682 | 67.679 | 22.256 |
| WILL %R | -33.333 | -59.184 | -48.333 | -39.726 | -84.775▼ |
| CCI | 50.985 | -19.511 | 35.180 | 64.362 | -82.008 |
|
Tuesday, October 19, 2021 04:00 AM
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today reported new safety data from the first lentiviral ...
|
|
Monday, October 18, 2021 04:50 AM
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.
|
|
Monday, October 18, 2021 04:34 AM
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/10/21 | 5.60 | 5.805 | 5.57 | 5.67 | 150,231 |
| 18/10/21 | 5.80 | 5.80 | 5.505 | 5.57 | 197,968 |
| 15/10/21 | 5.94 | 5.94 | 5.69 | 5.80 | 281,035 |
| 14/10/21 | 5.69 | 5.96 | 5.61 | 5.86 | 314,736 |
| 13/10/21 | 5.52 | 5.73 | 5.4904 | 5.63 | 211,585 |
| 12/10/21 | 5.55 | 5.71 | 5.47 | 5.66 | 230,219 |
| 11/10/21 | 5.54 | 5.6611 | 5.49 | 5.51 | 107,212 |
| 08/10/21 | 5.60 | 5.6498 | 5.4303 | 5.54 | 253,812 |
| 07/10/21 | 5.60 | 5.78 | 5.53 | 5.60 | 198,659 |
| 06/10/21 | 5.24 | 5.74 | 5.24 | 5.61 | 221,064 |
|
|
||||
|
|
||||
|
|